Aspira Pathlab Faces Intense Selling Pressure Amid Significant Stock Decline
Aspira Pathlab & Diagnostics Ltd is experiencing significant selling pressure, marked by a 4.99% decline in a single day and an 18.53% drop over the past week. This follows six consecutive days of losses, raising concerns about market sentiment despite a strong annual performance.
Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with its stock price down 4.99% in a single day, contrasting sharply with the Sensex, which gained 0.54% during the same period. Over the past week, Aspira Pathlab has lost 18.53%, while the Sensex fell by just 1.11%. This marks the sixth consecutive day of losses for Aspira Pathlab, resulting in a total decline of 24.36% over this timeframe. The stock opened at Rs 76.93 today, reflecting a gap down of 4.99%, and reached an intraday low of Rs 76.93, indicating a lack of upward movement throughout the trading session.
Despite a strong performance over the past year, where the stock surged by 133.97% compared to the Sensex's 3.42%, recent trends suggest a shift in market sentiment. The stock's performance relative to its moving averages shows it is currently above the 100-day and 200-day averages but below the 5-day, 20-day, and 50-day averages, indicating potential volatility. Factors contributing to this selling pressure may include broader market dynamics and sector-specific challenges within the hospital and healthcare services industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
